[Translation] A multicenter, randomized, double-blind, placebo-controlled, dose-finding phase IIa clinical trial of HW021199 tablets in the treatment of idiopathic pulmonary fibrosis
1、探索HW021199片治疗特发性肺纤维化的推荐剂量;
2、初步评估HW021199片治疗特发性肺纤维化的有效性和安全性;
3、评估HW021199片用于特发性肺纤维化患者的药代动力学和药效动力学特征。
[Translation] 1. Explore the recommended dose of HW021199 tablets for the treatment of idiopathic pulmonary fibrosis;
2. Preliminary evaluation of the effectiveness and safety of HW021199 tablets in the treatment of idiopathic pulmonary fibrosis;
3. Evaluate the pharmacokinetic and pharmacodynamic characteristics of HW021199 tablets in patients with idiopathic pulmonary fibrosis.